Literature DB >> 16860016

Recognition and treatment of depression and anxiety in patients with acute myocardial infarction.

Jeff C Huffman1, Felicia A Smith, Mark A Blais, Marguerite E Beiser, James L Januzzi, Gregory L Fricchione.   

Abstract

The objective of this study was to determine the ability of providers (medical residents and nurse practitioners) on inpatient cardiac units to recognize and appropriately treat patients with clinically significant depression and anxiety among a cohort admitted with acute myocardial infarction. Patients within 72 hours of acute myocardial infarction underwent screening with the Standardized Clinical Instrument for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition module for major depressive disorder (MDD), the Beck Depression Inventory (BDI-II), and the Beck Anxiety Inventory (BAI). In addition, the study psychiatrist and a treatment team clinician independently assessed whether they believed that patients had clinically significant depression or anxiety. Prescription of antidepressants and benzodiazepines during hospitalization was recorded by chart review. Assessments were completed for 74 patients. Providers identified < 15% of patients with current MDD or with a BDI score > or = 10; 11% of patients with current MDD had appropriate treatment with antidepressants. There was no significant correlation of providers' assessment of depression with current MDD, BDI scores, or psychiatrists' clinical assessment of depression. In contrast, providers identified 31% of patients with a BAI score > or = 10 and 50% of patients who were assessed by psychiatrists as anxious; > 80% of patients with high anxiety received benzodiazepines. Providers' assessments of anxiety were significantly correlated with BAI scores and with psychiatrists' clinical assessments. In conclusion, medical residents and nurse practitioners routinely under-recognize and undertreat depression among patients with acute myocardial infarction on inpatient cardiac units. Recognition and treatment of anxiety is substantially better, up to 50% of patients who are found to be anxious by psychiatrists after acute myocardial infarction remain unrecognized.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860016     DOI: 10.1016/j.amjcard.2006.02.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  35 in total

1.  Posttraumatic growth in coronary artery disease outpatients: relationship to degree of trauma and health service use.

Authors:  Yvonne W Leung; David A Alter; Peter L Prior; Donna E Stewart; Jane Irvine; Sherry L Grace
Journal:  J Psychosom Res       Date:  2012-01-28       Impact factor: 3.006

2.  Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation.

Authors:  Cai-Hua Sang; Ke Chen; Xue-Feng Pang; Jian-Zeng Dong; Xin Du; Hui Ma; Ji-Hong Liu; Chang-Sheng Ma; Ying-Xian Sun
Journal:  Clin Cardiol       Date:  2012-07-09       Impact factor: 2.882

Review 3.  AAFP guideline for the detection and management of post-myocardial infarction depression.

Authors: 
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

Review 4.  Depression and Anxiety in Heart Failure: A Review.

Authors:  Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman
Journal:  Harv Rev Psychiatry       Date:  2018 Jul/Aug       Impact factor: 3.732

5.  A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality.

Authors:  Bruce L Rollman; Bea Herbeck Belnap; Sati Mazumdar; Patricia R Houck; Fanyin He; Rene J Alvarez; Herbert C Schulberg; Charles F Reynolds; Dennis M McNamara
Journal:  J Card Fail       Date:  2011-12-22       Impact factor: 5.712

Review 6.  Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Manish K Jha; Arman Qamar; Muthiah Vaduganathan; Dennis S Charney; James W Murrough
Journal:  J Am Coll Cardiol       Date:  2019-04-16       Impact factor: 24.094

7.  An Examination of the Association Between Post-traumatic Growth and Stress Symptomatology in Cardiac Outpatients.

Authors:  Kirby Magid; Renée El-Gabalawy; Anbukarasi Maran; Eva R Serber
Journal:  J Clin Psychol Med Settings       Date:  2019-09

8.  ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

Authors:  C Noel Bairey Merz; Mark J Alberts; Gary J Balady; Christie M Ballantyne; Kathy Berra; Henry R Black; Roger S Blumenthal; Michael H Davidson; Sara B Fazio; Keith C Ferdinand; Lawrence J Fine; Vivian Fonseca; Barry A Franklin; Patrick E McBride; George A Mensah; Geno J Merli; Patrick T O'Gara; Paul D Thompson; James A Underberg
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

9.  The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Jeff C Huffman; Christopher M Celano; James L Januzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

10.  A prospective examination of antidepressant use and its correlates in patients with acute coronary syndrome.

Authors:  Sherry L Grace; Yvonne W Leung; Donna E Stewart
Journal:  Psychosomatics       Date:  2008 May-Jun       Impact factor: 2.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.